Why is Nanologica AB ?
- OPERATING CASH FLOW(Y) Highest at SEK -26.85 MM
- ROCE(HY) Highest at 31.15%
- RAW MATERIAL COST(Y) Fallen by -57.35% (YoY)
- Over the past year, while the stock has generated a return of -68.54%, its profits have risen by 23.5%
How much should you buy?
- Overall Portfolio exposure to Nanologica AB should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Nanologica AB for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at SEK -26.85 MM
Highest at 31.15%
Fallen by -57.35% (YoY
Highest at SEK 21.46 MM
Highest at SEK -4.29 MM
Highest at -20.01 %
Highest at SEK 65.19 MM
Highest at SEK 65.19 MM
Highest at SEK 0.72
Lowest at 2.23 times
At SEK 1.46 MM has Grown at 36.61%
Highest at 81.86 %
Here's what is working for Nanologica AB
Net Sales (SEK MM)
Pre-Tax Profit (SEK MM)
Net Profit (SEK MM)
Operating Cash Flows (SEK MM)
Net Sales (SEK MM)
Operating Profit (SEK MM)
Operating Profit to Sales
Pre-Tax Profit (SEK MM)
Net Profit (SEK MM)
EPS (SEK)
Raw Material Cost as a percentage of Sales
Depreciation (SEK MM)
Depreciation (SEK MM)
Here's what is not working for Nanologica AB
Interest Paid (SEK MM)
Inventory Turnover Ratio
Debt-Equity Ratio






